1. Home
  2. KOSS vs PMVP Comparison

KOSS vs PMVP Comparison

Compare KOSS & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$3.83

Market Cap

39.3M

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.31

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
PMVP
Founded
1953
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
79.5M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KOSS
PMVP
Price
$3.83
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.9K
894.8K
Earning Date
05-07-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
$12,624,170.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.93
N/A
52 Week Low
$3.61
$0.82
52 Week High
$8.59
$1.88

Technical Indicators

Market Signals
Indicator
KOSS
PMVP
Relative Strength Index (RSI) 36.05 41.81
Support Level N/A $1.26
Resistance Level $5.04 $1.50
Average True Range (ATR) 0.19 0.06
MACD -0.01 -0.04
Stochastic Oscillator 11.14 2.56

Price Performance

Historical Comparison
KOSS
PMVP

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: